Food Allergy Safety, Treatment, Education, and Research Act would amend FDA regulations to include sesame as major allergen and allow agency to add other food ingredients as major allergens based on prevalence and severity of allergic reactions. FDA, meanwhile, published guidance for voluntarily labeling sesame as an allergen while it develop its factors for evaluating which food allergens in addition to the eight already specified in its regulations should be designated as requiring additional controls, including allergen labeling.
The US House, a week after the Food and Drug Administration published guidance on voluntary labeling of sesame as an allergen, passed legislation expanding the agency’s research into sesame and other food allergens and broadening its authority for requiring related label changes.
The “Food Allergy Safety, Treatment, Education, and Research Act of 2019” (FASTER Act), HR 2117, introduced by Rep. Doris Matsui,...
Des recherches montrent que l’asthme et le diabète de type 2 (DT2) sont liés au-delà du hasard, partageant des facteurs inflammatoires et métaboliques. Cette association souligne l’importance d’une surveillance accrue et d’une prise en charge adaptée pour prévenir les complications chez les patients
Green Pharmaceuticals’ SnoreStop Nasal Spray, previously marketed as “NasoSpray,” still is available even though agency officials on multiple occasions for a month recommended a recall after an April inspection found “gross microbial contamination” in one lot.
Following Energy and Commerce Health Subcommittee hearing about FDA’s human food and tobacco programs on 10 September, gap between what the trade groups, committee leadership and the FDA each want more of doesn’t appear to be shrinking.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Week after publishing safety alert about OPMS Black Liquid Kratom “linked to serious adverse health effects, including death,” FDA announced market research “to understand and characterize emergent risk/safety and perceived benefits reportedly linked to kratom and psychedelics.” But it withdrew the study 10 days later.
Semi-annual regulatory agenda of non-binding target dates also sets December goal for an NPRM to recognize N-acetyl-L-cysteine as a lawful dietary ingredient. Like IND exemptions rule, item on NAC included for first time in FDA’s list.
In this installment of HBW Insight’s “Inside Regulatory Affairs” series, we hear from Sharee Crumbey and Monica Sharda, regulatory affairs specialists at The Honest Company, about the mounting challenges and rewards of the job.
